{"id":11708,"date":"2018-10-26T00:00:00","date_gmt":"2018-10-25T22:00:00","guid":{"rendered":"http:\/\/web-server-devel.mgc.es\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/"},"modified":"2019-11-22T12:42:23","modified_gmt":"2019-11-22T11:42:23","slug":"psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya","status":"publish","type":"post","link":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/","title":{"rendered":"Psoriasi, una malaltia que afecta m\u00e9s d&#8217;un mili\u00f3 de persones a Espanya"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\"><p class=\"ez-toc-title\" style=\"cursor:inherit\">\u00cdndex de continguts<\/p>\n<\/div><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#Que_es_la_psoriasi\" >Qu\u00e8 \u00e9s la psoriasi?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#Artritis_psoriasica\" >Artritis psori\u00e0sica<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#Com_afecta_la_qualitat_de_vida_dels_pacients\" >Com afecta la qualitat de vida dels pacients?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#Relacio_amb_mes_patologies\" >Relaci\u00f3 amb m\u00e9s patologies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#Tractament_de_la_psoriasi\" >Tractament de la psoriasi<\/a><\/li><\/ul><\/nav><\/div>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-5288\" src=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2018\/10\/psoriasis-cat.jpg\" alt=\"psoriasi\" width=\"800\" height=\"474\" \/><\/p>\n<p>Al nostre pa\u00eds, aproximadament un 2,3% de la poblaci\u00f3 t\u00e9 psoriasi, cosa que suposa que m\u00e9s d&#8217;un mili\u00f3 de persones conviuen amb aquesta malaltia. A m\u00e9s d&#8217;afectar la pell, pot contribuir a l&#8217;aparici\u00f3 de m\u00e9s patologies. Amb motiu del Dia Mundial de la Psoriasi, repassem alguns punts clau d&#8217;aquesta malaltia autoimmune.<!--more--><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Que_es_la_psoriasi\"><\/span>Qu\u00e8 \u00e9s la psoriasi?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>La psoriasi \u00e9s una <strong>malaltia inflamat\u00f2ria cr\u00f2nica no contagiosa que afecta la pell i, ocasionalment, les articulacions<\/strong>, que es caracteritza per l&#8217;aparici\u00f3 d&#8217;irritaci\u00f3 i lesions per descamaci\u00f3. No \u00e9s una malaltia heredit\u00e0ria, per\u00f2 hi ha una predisposici\u00f3 gen\u00e8tica, de manera que un ter\u00e7 dels pacients afectats t\u00e9 familiars directes amb psoriasi. De tota manera, per al desenvolupament de la malaltia es necessiten, a m\u00e9s, uns altres factors desencadenants.<\/p>\n<p>Es produeix a partir d&#8217;una <strong>alteraci\u00f3 en el sistema immunitari<\/strong>, que activa de manera indeguda els limf\u00f2cits T de la sang (els que ajuden a protegir el cos contra infeccions i malalties) i causa respostes com ara la proliferaci\u00f3 i desenvolupament dels vasos sanguinis de la pell i una acceleraci\u00f3 del creixement de les c\u00e8l\u00b7lules cut\u00e0nies.<\/p>\n<p>La psoriasi pot apar\u00e8ixer <strong>a qualsevol edat<\/strong>, tot i que es manifesta m\u00e9s sovint entre els 15 i els 35 anys, i afecta per igual homes i dones. Pot apar\u00e8ixer <strong>en qualsevol part del cos<\/strong>, incloses mucoses i ungles, encara que sol afectar m\u00e9s les zones on la pell est\u00e0 en m\u00e9s contacte amb la zona \u00f2ssia (colzes, genolls, cuir cabellut, regi\u00f3 sacra, etc.).<\/p>\n<p><strong>Es manifesta de forma molt variable<\/strong>: en el 80% dels casos solen apar\u00e8ixer plaques de mida variable, enrogides i recobertes d&#8217;escates blanquinoses de gruix variable, que piquen i que poden afectar tant zones concretes com extensions m\u00e9s grans. Una altra de les formes m\u00e9s comunes de la psoriasi \u00e9s l&#8217;aparici\u00f3 a la zona del tronc o dels bra\u00e7os, de plaques petites, com si fossin petites gotes localitzades, que sorgeixen despr\u00e9s d&#8217;un quadre gripal.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-5290\" src=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2018\/10\/psoriasis-nuca.jpg\" alt=\"psoriasis nuca\" width=\"800\" height=\"533\" \/><\/p>\n<h2 style=\"font-style: normal\"><span class=\"ez-toc-section\" id=\"Artritis_psoriasica\"><\/span>Artritis psori\u00e0sica<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>L&#8217;artritis psori\u00e0sica \u00e9s una malaltia cr\u00f2nica inflamat\u00f2ria que <strong>afecta les articulacions, els tendons i pot afectar tamb\u00e9 la columna vertebral<\/strong>, i que ocasiona un dolor constant en els pacients. Es tracta d&#8217;una malaltia cr\u00f2nica que ha de ser diagnosticada al m\u00e9s aviat possible per aconseguir una estabilitzaci\u00f3 de la malaltia i aconseguir que el pacient pugui fer una vida normal. A Espanya, l&#8217;artritis psori\u00e0sica afecta m\u00e9s de 200.000 persones.<\/p>\n<p>En la majoria dels pacients sol apar\u00e8ixer primer la malaltia de la pell, la psoriasi, i amb el pas dels anys (entre 5 i 15 anys), l&#8217;afectaci\u00f3 de les articulacions o de l&#8217;esquena.<\/p>\n<p>Aproximadament <strong>un ter\u00e7 dels pacients amb psoriasi a la pell desenvolupa una malaltia reumatol\u00f2gica<\/strong>. \u00c9s important el tractament preco\u00e7 perqu\u00e8 si es controla la inflamaci\u00f3 es pot evitar la degeneraci\u00f3 articular que vindr\u00e0 posteriorment. Els pacients m\u00e9s afectats de psoriasi a la pell, al cap i a les ungles s\u00f3n els que tenen m\u00e9s probabilitat de desenvolupar una artritis psori\u00e0sica. Tamb\u00e9 dep\u00e8n dels s\u00edmptomes del pacient i de l&#8217;afectaci\u00f3 inflamat\u00f2ria que s&#8217;observa en les proves d&#8217;imatge.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-5291\" src=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2018\/10\/psoriasis-artritis.jpg\" alt=\"artritis psori\u00e1sica\" width=\"800\" height=\"532\" \/><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Com_afecta_la_qualitat_de_vida_dels_pacients\"><\/span>Com afecta la qualitat de vida dels pacients?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A m\u00e9s de les mol\u00e8sties pr\u00f2pies de la malaltia, en els casos de psoriasi extensa s\u2019origina un <strong>impacte psicol\u00f2gic<\/strong>: gran part dels pacients poden sentir-se estigmatitzats, cosa que provoca nivells baixos d&#8217;autoestima que afecten en gran mesura la seva capacitat d&#8217;interacci\u00f3 social i les seves relacions \u00edntimes. M\u00e9s de la meitat de les persones que viuen amb psoriasi estan afectades psicol\u00f2gicament de manera significativa.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Relacio_amb_mes_patologies\"><\/span>Relaci\u00f3 amb m\u00e9s patologies<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>La psoriasi no \u00e9s una condici\u00f3 \u00fanica de la pell, \u00e9s una malaltia inflamat\u00f2ria sist\u00e8mica en qu\u00e8 el proc\u00e9s inflamatori <strong>pot contribuir a l&#8217;aparici\u00f3 de m\u00e9s patologies<\/strong>, principalment malalties cardiovasculars, alteracions del fetge (6 de cada 10 pacients amb psoriasi poden desenvolupar una malaltia hep\u00e0tica), obesitat i artritis psori\u00e0sica. Un estudi de 2016 va revelar que el 85% dels pacients amb psoriasi t\u00e9 una malaltia associada. Per aquest motiu, \u00e9s important promoure la formaci\u00f3 del pacient en l&#8217;\u00e0mbit cl\u00ednic, terap\u00e8utic, social i psicol\u00f2gic, aix\u00ed com la informaci\u00f3 d&#8217;aquesta comorbiditat entre els professionals d&#8217;atenci\u00f3 prim\u00e0ria.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-5289\" src=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2018\/10\/psoriasis-crema.jpg\" alt=\"psoriasis crema\" width=\"800\" height=\"536\" \/><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Tractament_de_la_psoriasi\"><\/span>Tractament de la psoriasi<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No totes les psoriasis s\u00f3n iguals i el tractament dep\u00e8n del tipus de psoriasi, de la localitzaci\u00f3, de la gravetat, de l&#8217;edat del pacient i de la seva hist\u00f2ria cl\u00ednica. Tot i que s&#8217;estan aconseguint molts aven\u00e7os, actualment <strong>no hi ha un tractament que assoleixi una curaci\u00f3 definitiva<\/strong>.<\/p>\n<p>El dermat\u00f2leg pot aconsellar <strong>tractaments t\u00f2pics<\/strong> per als pacients amb psoriasi molt localitzada, o la fototer\u00e0pia. En casos m\u00e9s intensos o quan no es respon als tractaments t\u00f2pics, es poden utilitzar, a m\u00e9s, els <strong>tractaments sist\u00e8mics<\/strong>, que actuen des de l&#8217;interior: medicaments orals, subcutanis, intramusculars o intravenosos. I en els casos en qu\u00e8 la psoriasi es fa resistent a un tractament o aquest deixa de ser efectiu, entrem en les <strong>ter\u00e0pies biol\u00f2giques<\/strong>: medicaments sintetitzats mitjan\u00e7ant biotecnologia, dirigits cap a mol\u00e8cules concretes, de forma espec\u00edfica, que bloquegen l&#8217;acci\u00f3 d&#8217;algunes c\u00e8l\u00b7lules immunol\u00f2giques o dels seus transmissors qu\u00edmics involucrats en el proc\u00e9s de la psoriasi.<\/p>\n<p>En general, el tractament de la psoriasi ha de ser un tractament integrat, dirigit no solament a la millora de les manifestacions cut\u00e0nies de la malaltia, sin\u00f3 tamb\u00e9 a la cura psicol\u00f2gica del pacient. Les esperances estan posades en el futur: la investigaci\u00f3 avan\u00e7a cada any i \u00e9s possible que amb el pas del temps es puguin portar a terme ter\u00e0pies personalitzades espec\u00edfiques per a cada pacient que arribi a remetre la malaltia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Al nostre pa\u00eds, aproximadament un 2,3% de la poblaci\u00f3 t\u00e9 psoriasi, cosa que suposa que m\u00e9s d&#8217;un mili\u00f3 de persones conviuen amb aquesta malaltia. A m\u00e9s d&#8217;afectar la pell, pot contribuir a l&#8217;aparici\u00f3 de m\u00e9s patologies. Amb motiu del Dia Mundial de la Psoriasi, repassem alguns punts clau d&#8217;aquesta malaltia autoimmune.<\/p>\n","protected":false},"author":3,"featured_media":14550,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[994,15],"tags":[543],"class_list":["post-11708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dermatologia","category-salut","tag-psoriasis-ca-2"],"featured_image_src":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg","author_info":{"display_name":"Revista Inter\u00e8s Mutu","author_link":"https:\/\/www.mgc.es\/ca\/blog\/author\/interesmutu\/"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Psoriasi, una malaltia que afecta m\u00e9s d&#039;un mili\u00f3 de persones a Espanya - MGC M\u00fatua<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Psoriasi, una malaltia que afecta m\u00e9s d&#039;un mili\u00f3 de persones a Espanya - MGC M\u00fatua\" \/>\n<meta property=\"og:description\" content=\"Al nostre pa\u00eds, aproximadament un 2,3% de la poblaci\u00f3 t\u00e9 psoriasi, cosa que suposa que m\u00e9s d&#8217;un mili\u00f3 de persones conviuen amb aquesta malaltia. A m\u00e9s d&#8217;afectar la pell, pot contribuir a l&#8217;aparici\u00f3 de m\u00e9s patologies. Amb motiu del Dia Mundial de la Psoriasi, repassem alguns punts clau d&#8217;aquesta malaltia autoimmune.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/\" \/>\n<meta property=\"og:site_name\" content=\"MGC M\u00fatua\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/mgcmutua\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-25T22:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-22T11:42:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"474\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Revista Inter\u00e8s Mutu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mgcmutua\" \/>\n<meta name=\"twitter:site\" content=\"@mgcmutua\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Revista Inter\u00e8s Mutu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Psoriasi, una malaltia que afecta m\u00e9s d'un mili\u00f3 de persones a Espanya - MGC M\u00fatua","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/","og_locale":"ca_ES","og_type":"article","og_title":"Psoriasi, una malaltia que afecta m\u00e9s d'un mili\u00f3 de persones a Espanya - MGC M\u00fatua","og_description":"Al nostre pa\u00eds, aproximadament un 2,3% de la poblaci\u00f3 t\u00e9 psoriasi, cosa que suposa que m\u00e9s d&#8217;un mili\u00f3 de persones conviuen amb aquesta malaltia. A m\u00e9s d&#8217;afectar la pell, pot contribuir a l&#8217;aparici\u00f3 de m\u00e9s patologies. Amb motiu del Dia Mundial de la Psoriasi, repassem alguns punts clau d&#8217;aquesta malaltia autoimmune.","og_url":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/","og_site_name":"MGC M\u00fatua","article_publisher":"https:\/\/www.facebook.com\/mgcmutua","article_published_time":"2018-10-25T22:00:00+00:00","article_modified_time":"2019-11-22T11:42:23+00:00","og_image":[{"width":800,"height":474,"url":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg","type":"image\/jpeg"}],"author":"Revista Inter\u00e8s Mutu","twitter_card":"summary_large_image","twitter_creator":"@mgcmutua","twitter_site":"@mgcmutua","twitter_misc":{"Escrit per":"Revista Inter\u00e8s Mutu","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#article","isPartOf":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/"},"author":{"name":"Revista Inter\u00e8s Mutu","@id":"https:\/\/www.mgc.es\/#\/schema\/person\/010c961d9c9acf38f11187a02b646c16"},"headline":"Psoriasi, una malaltia que afecta m\u00e9s d&#8217;un mili\u00f3 de persones a Espanya","datePublished":"2018-10-25T22:00:00+00:00","dateModified":"2019-11-22T11:42:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/"},"wordCount":981,"commentCount":0,"publisher":{"@id":"https:\/\/www.mgc.es\/#organization"},"image":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg","keywords":["psoriasis"],"articleSection":["Dermatologia","Salut i medicina"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#respond"]}]},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/","url":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/","name":"Psoriasi, una malaltia que afecta m\u00e9s d'un mili\u00f3 de persones a Espanya - MGC M\u00fatua","isPartOf":{"@id":"https:\/\/www.mgc.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#primaryimage"},"image":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg","datePublished":"2018-10-25T22:00:00+00:00","dateModified":"2019-11-22T11:42:23+00:00","breadcrumb":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#primaryimage","url":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg","contentUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/psoriasis.jpg","width":800,"height":474},{"@type":"BreadcrumbList","@id":"https:\/\/www.mgc.es\/ca\/blog\/psoriasi-una-malaltia-que-afecta-mes-dun-milio-de-persones-a-espanya\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mgc.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Psoriasi, una malaltia que afecta m\u00e9s d&#8217;un mili\u00f3 de persones a Espanya"}]},{"@type":"WebSite","@id":"https:\/\/www.mgc.es\/#website","url":"https:\/\/www.mgc.es\/","name":"MGC M\u00fatua","description":"MGC M\u00fatua \u00e9s una entitat asseguradora sense \u00e0nim de lucre constitu\u00efda al 1982 i especialitzada en assegurances de salut i assist\u00e8ncia.","publisher":{"@id":"https:\/\/www.mgc.es\/#organization"},"alternateName":"MGC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mgc.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.mgc.es\/#organization","name":"MGC Mutua","alternateName":"MGC","url":"https:\/\/www.mgc.es\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.mgc.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.mgc.es\/wp-content\/uploads\/2020\/03\/mgcmutua_h2_2t_reduccions.png","contentUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2020\/03\/mgcmutua_h2_2t_reduccions.png","width":303,"height":165,"caption":"MGC Mutua"},"image":{"@id":"https:\/\/www.mgc.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/mgcmutua","https:\/\/x.com\/mgcmutua","https:\/\/www.youtube.com\/c\/MGCMutua"]},{"@type":"Person","@id":"https:\/\/www.mgc.es\/#\/schema\/person\/010c961d9c9acf38f11187a02b646c16","name":"Revista Inter\u00e8s Mutu","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/52302d684339b9d7bf5691e2ad00835d62ce3b4a435f21ca9f21fbe39c63cb1b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/52302d684339b9d7bf5691e2ad00835d62ce3b4a435f21ca9f21fbe39c63cb1b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52302d684339b9d7bf5691e2ad00835d62ce3b4a435f21ca9f21fbe39c63cb1b?s=96&d=mm&r=g","caption":"Revista Inter\u00e8s Mutu"}}]}},"_links":{"self":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts\/11708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/comments?post=11708"}],"version-history":[{"count":1,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts\/11708\/revisions"}],"predecessor-version":[{"id":15224,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts\/11708\/revisions\/15224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/media\/14550"}],"wp:attachment":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/media?parent=11708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/categories?post=11708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/tags?post=11708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}